BioSpace News Archive

Zylox-Tonbridge was Added to the FTSE Global Equity Index Series

Zylox-Tonbridge is pleased to learn that the Company’s stock was added to the FTSE Global Equity Index Series, including FTSE Global Total-Cap Index and FTSE Global Micro Cap Index, according to the results of the semi-annual review of FTSE GEIS.

September 18, 2023

·

1 min read

Notice of Extraordinary General Meeting Promore Pharma AB (Publ)

Promore Pharma AB will hold an Extraordinary General Meeting on Thursday, 5 October 2023 at 10.00 am, in Advokaterna Liman & Partners AB:s premises at Grev Turegatan 38, 114 38 Stockholm.

September 18, 2023

·

6 min read

Business

AiViva Biopharma Appoints Lester J. Kaplan, PhD to the Board of Directors

AiViva Biopharma Inc., a clinical-stage biotechnology company developing innovative therapies to address major unmet medical needs, announced the appointment of Dr. Lester J. Kaplan, PhD to its board of directors.

September 18, 2023

·

1 min read

Genetown

Atrial Fibrillation Study with Abelacimab Stopped Early by the Data Monitoring Committee Due to an Overwhelming Reduction in Bleeding as Compared to a DOAC (Direct Oral Anticoagulant)

Anthos Therapeutics, Inc., a clinical stage company developing innovative therapies for cardiovascular diseases, founded by Blackstone Life Sciences, announced that the AZALEA-TIMI 71 Phase 2 study in 1,287 patients with atrial fibrillation at moderate-to-high risk of stroke, met its primary endpoint.

September 18, 2023

·

8 min read

Drug Development

Nuvalent to Present Preliminary Data from ALKOVE-1 Phase 1/2 Clinical Trial of NVL-655 at 35th AACR-NCI-EORTC Symposium

Nuvalent, Inc. announced it will present preliminary dose-escalation data from its ongoing ALKOVE-1 Phase 1/2 clinical trial of NVL-655 at the 35th AACR-NCI-EORTC Symposium taking place October 11-15, 2023, in Boston, Massachusetts.

September 18, 2023

·

5 min read

Pharm Country

NRx Pharmaceuticals to Present at the Sidoti Virtual Small Cap Conference

NRx Pharmaceuticals, Inc. announced that Stephen Willard, J.D., Chief Executive Officer and Dr. Jonathan Javitt, Chief Scientist of NRx Pharmaceuticals, will present a company overview at the Sidoti Virtual Small Cap Conference on Thursday, September 21, 2023, at 9:15AM ET.

September 18, 2023

·

4 min read

Genetown

Orchard Therapeutics Announces Acceptance of Biologics License Application for OTL-200 in MLD and Receives Priority Review

Orchard Therapeutics (Nasdaq: ORTX), a global gene therapy leader, today announced the U.S. Food and Drug Administration (FDA) has accepted the filing of its Biologics License Application (BLA) for OTL-200 in metachromatic leukodystrophy (MLD) under Priority Review.

September 18, 2023

·

8 min read

Business

Black Diamond Therapeutics Announces CEO Transition

Black Diamond Therapeutics, Inc. announced that current Chairman of the Board, Mark Velleca, M.D., Ph.D., has been appointed as Chief Executive Officer (CEO) effective immediately.

September 18, 2023

·

4 min read

Drug Development

AlzeCure Gets an Abstract on Phase II Clinical Data with ACD440 for Neuropathic Pain Accepted at Pain Conference

AlzeCure Pharma announced that an abstract on ACD440, the leading non-opioid drug candidate in the Painless platform, has been accepted for presentation at the annual pain conference to be held by the Swedish Pain Society in Uppsala, Sweden, on October 12-13.

September 18, 2023

·

5 min read

Drug Development

Peer-Reviewed Publication of Positive Preclinical Data of SiSaf’s SIS-ADO2 siRNA Program to Treat Rare Genetic Bone Disorder Osteopetrosis

SiSaf Ltd, an RNA therapeutics company, is pleased to announce the publication in the peer-reviewed journal Molecular Therapy Nucleic Acids of positive in vivo data demonstrating the safety and efficacy of its siRNA therapy for Autosomal Dominant Osteopetrosis 2.

September 18, 2023

·

3 min read